Celebrex inhibits burden of skin cancer in high-risk patients, research finds
Wednesday, January 6, 2010 - 02:07
in Health & Medicine
People with the heritable disorder of the skin called Gorlin syndrome who are genetically predisposed to develop basal cell carcinoma of the skin may have a new chemoprevention therapy on the horizon.